Evaluation of the Implementation of a Quality Improvement Program Through Morbidity and Mortality Reviews
1 other identifier
observational
13
1 country
1
Brief Summary
Morbidity and mortality reviews represent an opportunity to discuss adverse events and healthcare issues. Aim is to report the first experience of implementing a standardized procedure of morbidity and mortality reviews, and assess its impact on quality improvement.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jan 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2020
CompletedFirst Submitted
Initial submission to the registry
March 9, 2022
CompletedFirst Posted
Study publicly available on registry
March 18, 2022
CompletedApril 5, 2022
March 1, 2022
12 months
March 9, 2022
March 25, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Process assessment
evaluation of the number of MMRs, numbers and categories of identified contributing factors, number and types of recommendations and number and types of implemented recommendations.
one year
Eligibility Criteria
Patients who underwent a curative surgical procedure for a digestive cancer in our department during the study period and who presented severe adverse events in 90 post operative day
You may qualify if:
- severe adverse events defined as postoperative morbidity \> 3a according to the Clavien Dindo grading system
- within the first 90 postoperative days of surgery
- Cases discussed in a morbidity and mortality review
You may not qualify if:
- Cases not discussed in a morbidity mortality review
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Institute of Oncology
Rabat, 10090, Morocco
Related Publications (4)
Houssaini K, Lahnaoui O, Souadka A, Majbar MA, Ghanam A, El Ahmadi B, Belkhadir Z, Amrani L, Mohsine R, Benkabbou A. Contributing factors to severe complications after liver resection: an aggregate root cause analysis in 105 consecutive patients. Patient Saf Surg. 2020 Sep 29;14:36. doi: 10.1186/s13037-020-00261-7. eCollection 2020.
PMID: 33014137BACKGROUNDSouadka A, Benkabbou A, Al Ahmadi B, Boutayeb S, Majbar MA. Preparing African anticancer centres in the COVID-19 outbreak. Lancet Oncol. 2020 May;21(5):e237. doi: 10.1016/S1470-2045(20)30216-3. Epub 2020 Apr 3. No abstract available.
PMID: 32251622BACKGROUNDSouadka A, Majbar MA, Essangri H, Amrani L, Benkabbou A, Mohsine R, Souadka A. Functional outcomes over time following perineal pseudocontinent colostomy reconstruction after abdominoperineal resection for ultralow rectal adenocarcinoma. J Surg Oncol. 2020 Sep;122(4):753-759. doi: 10.1002/jso.26074. Epub 2020 Jun 20.
PMID: 32563198BACKGROUNDMajbar MA, Courtot L, Dahbi-Skali L, Rafik A, Jouppe PO, Moussata D, Benkabbou A, Mohsine R, Ouaissi M, Souadka A. Two-step pull-through colo-anal anastomosis aiming to avoid stoma in rectal cancer surgery: A "real life" study in a developing country. J Visc Surg. 2022 Jun;159(3):187-193. doi: 10.1016/j.jviscsurg.2021.04.004. Epub 2021 Jun 4.
PMID: 34092526BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
Oumayma Lahnaoui, MD
National Institute of Oncology
- STUDY DIRECTOR
Anass Majbar, MD
National Institute of Oncology
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor MA Majbar
Study Record Dates
First Submitted
March 9, 2022
First Posted
March 18, 2022
Study Start
January 1, 2019
Primary Completion
December 31, 2019
Study Completion
January 31, 2020
Last Updated
April 5, 2022
Record last verified: 2022-03